跳至主要内容
临床试验/CTRI/2020/03/024343
CTRI/2020/03/024343尚未招募4 期

Comparison of ceftazidime-avibactam plus aztreonam with meropenem plus colistin in Intensive Care Unit patients with Extensively drug resistant (XDR) Gram-Negative Bacterial (GNB) infection- a Prospective Observational study

FMRI0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Any body-fluid culture positive for gram negative Enterobacteriaceae
  • 2. Sensitive to only one or two group of antibiotics (carbapenem resistant)
  • 3. Onset of symptoms >=48 hours after admission to hospital or history of hospital admission in past 30 days
  • 4.>=1 systemic sign of infection
  • -Fever (temperature >38°C) or hypothermia (temperature <35°C)
  • -White blood cell count >11,000 or <4000 cells/mm3, or >15% band forms

排除标准

  • 1.On triple/multi drug therapy for GNB
  • 2.Patient refusal to participate in the study
  • 3.Follow up drop outs
  • 4.Need to change to other drugs during the study
  • 5.Known allergy to study drugs
  • 6.Previous inclusion in the study
  • 7.Polymicrobial infection where one or more of the clinically-significant gram-negative bacteria are susceptible to any beta-lactam
  • 8.Pregnant patients.

研究者

发起方
FMRI

相似试验